Mechanisms of disease: the oxidative stress theory of diabetic neuropathy - sprookjes - yvandenbroek - TriplyDB

Mechanisms of disease: the oxidative stress theory of diabetic neuropathy

Mechanisms of disease: the oxidative stress theory of diabetic neuropathy

http://www.wikidata.org/entity/Q34553052

about

Growth factors for treating diabetic foot ulcers Growth factors for treating diabetic foot ulcers Perspectives on systems biology applications in diabetic kidney disease Chromium picolinate and chromium histidinate protects against renal dysfunction by modulation of NF-κB pathway in high-fat diet fed and Streptozotocin-induced diabetic rats Fructose: it's "alcohol without the buzz".Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: Potential application in the treatment of diabetic neuropathy Literature-based discovery of diabetes- and ROS-related targets.Tetrahydrobiopterin (BH4), a cofactor for nNOS, restores gastric emptying and nNOS expression in female diabetic rats The Association between Serum GGT Concentration and Diabetic Peripheral Polyneuropathy in Type 2 Diabetic Patients.Neurotoxic effects of iron overload under high glucose concentration.Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential Puerarin prevents high glucose-induced apoptosis of Schwann cells by inhibiting oxidative stress.Ginsenoside Rb1 relieves glucose fluctuation-induced oxidative stress and apoptosis in Schwann cells.Oxidative stress and the etiology of insulin resistance and type 2 diabetes.Stem cells in the diabetic infarcted heart Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity: National Health and Nutrition Examination Survey 2001-2004.Update on the management of diabetic polyneuropathies.The identification of gene expression profiles associated with progression of human diabetic neuropathy Antioxidation and anti-inflammatory activity of Tang Bi Kang in rats with diabetic peripheral neuropathy.Significant in vivo anti-inflammatory activity of Pytren4Q-Mn a superoxide dismutase 2 (SOD2) mimetic scorpiand-like Mn (II) complex.Phenotypic changes in diabetic neuropathy induced by a high-fat diet in diabetic C57BL/6 mice.Bone marrow expression of poly(ADP-ribose) polymerase underlies diabetic neuropathy via hematopoietic-neuronal cell fusion.Neuroprotective effects of Gymnema sylvestre on streptozotocin-induced diabetic neuropathy in rats.Jinmaitong decreases sciatic nerve DNA oxidative damage and apoptosis in a streptozotocin-induced diabetic rat model.Effect of Cosmos caudatus (Ulam raja) supplementation in patients with type 2 diabetes: Study protocol for a randomized controlled trial.Modulating Molecular Chaperones Improves Mitochondrial Bioenergetics and Decreases the Inflammatory Transcriptome in Diabetic Sensory Neurons Tang-Tong-Fang Confers Protection against Experimental Diabetic Peripheral Neuropathy by Reducing Inflammation.Mutations in the Heme Exporter FLVCR1 Cause Sensory Neurodegeneration with Loss of Pain Perception Proteomic analysis of protease resistant proteins in the diabetic rat kidney Age-related obesity and type 2 diabetes dysregulate neuronal associated genes and proteins in humans.Pathogenesis of diabetic neuropathy: bad to the bone.Diabetes, lower extremity amputation, loss of protective sensation, and neuronal nitric oxide synthase associated protein in the chronic renal insufficiency cohort study Berberine ameliorates cold and mechanical allodynia in a rat model of diabetic neuropathy Effect of glycemic control on corneal nerves and peripheral neuropathy in streptozotocin-induced diabetic C57Bl/6J mice.Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy Effect of Treatment with Salsalate, Menhaden Oil, Combination of Salsalate and Menhaden Oil, or Resolvin D1 of C57Bl/6J Type 1 Diabetic Mouse on Neuropathic Endpoints.The functional role of MnSOD as a biomarker of human diseases and therapeutic potential of a new isoform of a human recombinant MnSOD Chewing the fat: genetic approaches to model dyslipidemia-induced diabetic neuropathy in mice Hyperlipidemia: a new therapeutic target for diabetic neuropathy.Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) is a novel therapeutic target for diabetic complications.

P2860

Q24186333-27ECDD88-4E30-418C-B0F3-BF1C99CBF222 Q24235049-D3056693-7F29-408B-ADB9-6F862B4C2B5A Q26823206-BC8A40D8-B1AA-4204-A582-B0F19BF3D16D Q28384183-18843B0E-CF00-45A2-800B-5E983AEF5737 Q30428239-252D6E7B-1106-4F52-B1B9-21DF67757F5F Q33708002-6FDABF91-2ECE-424A-950F-8B42322BEBE7 Q33729719-A505FFBE-CBBB-41F3-939C-8A552C2A0DF9 Q33840677-2F0A2D44-8EE6-4665-ACC4-5573BE77CF9B Q33904484-5D5CA051-154C-49B8-91CE-7BDD8C793B7F Q34095052-A2C07029-2CBC-4182-B270-AD4D5FB7BFB0 Q34110107-EA20D876-D0B8-440A-BC55-39FC7979757D Q34358231-C51A46F0-7767-457E-B05B-78C0D9DA9F51 Q34720246-3082E5A7-29A4-4384-90EB-A587653FA701 Q34768229-4A91C025-9F4C-44FB-8130-0DB5A0C2636A Q34773408-97174000-B235-442C-9925-2F992C408DB3 Q35060261-A6A7A58F-9F8C-49BF-9A16-1F58D304108B Q35178801-6DA7F50B-9561-4AE2-B0E2-0933138A3BB8 Q35540055-9755B4AD-A1A1-4CEC-8305-21ED275AB53F Q35562478-53D767D0-74E8-446A-A1B0-19343BF5522C Q35572108-2B0E8378-3642-4AC9-A43E-B8D2723C354C Q35579658-E3298745-C075-499B-BE52-54E829B56115 Q35648004-126A0A48-0349-4D0E-BB11-0463CD7B849A Q35754191-099962DC-9821-4D18-BE39-E71E211C74A1 Q35870512-375F2E89-EFFB-4DA3-9BAE-2A76F5D3EEC9 Q35937965-9D5C9F76-9AC9-410F-AD44-491A6C8FCD48 Q36070681-43B33CB7-4748-4B53-99BF-D2A99A1AAED9 Q36204351-71083784-E050-4B7C-8FDA-222C972636F5 Q36214268-A3CBF460-F001-4623-AB71-BA57E31B4FF6 Q36508145-C5E05367-E4CF-45BB-99B2-703CA931F247 Q36557442-953B3C66-349A-47D4-A7BE-EEFD82267241 Q36796321-14FC4345-1CFB-45A1-85E1-C5C121DAD6A3 Q36888085-F542704F-1C42-4EEE-BA33-260135DA0731 Q36933488-48B696B6-9511-4021-96C5-BBE8571E899C Q37179497-E7E5F753-12E5-452F-A23C-AF53A4E3C41A Q37325187-D0C014A3-AADF-4E08-BB75-4B85B6E35F9A Q37330126-BCCFF72B-A9A9-409A-998A-6F55158FB8C1 Q37552213-560D7E47-5647-4D47-A1BD-143ED9B97287 Q37572538-AC57D757-33EB-487B-8A18-1858FDC372BB Q37659233-4E6648A2-2028-485F-9E21-21B529E91980 Q38097416-FD1C04FE-9CBC-4D0F-A6B2-3E527B33C0A6

P2860

Mechanisms of disease: the oxidative stress theory of diabetic neuropathy

http://www.wikidata.org/entity/Q34553052

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Mechanisms of disease: the oxidative stress theory of diabetic neuropathy

@ast

Mechanisms of disease: the oxidative stress theory of diabetic neuropathy

@en

Mechanisms of disease: the oxidative stress theory of diabetic neuropathy

@nl

type

label

Mechanisms of disease: the oxidative stress theory of diabetic neuropathy

@ast

Mechanisms of disease: the oxidative stress theory of diabetic neuropathy

@en

Mechanisms of disease: the oxidative stress theory of diabetic neuropathy

@nl

prefLabel

Mechanisms of disease: the oxidative stress theory of diabetic neuropathy

@ast

Mechanisms of disease: the oxidative stress theory of diabetic neuropathy

@en

Mechanisms of disease: the oxidative stress theory of diabetic neuropathy

@nl

P1433

Q34553052-884A7366-CBE3-434A-9856-96C4DB104C62

P1476

Q34553052-22D984C4-D578-401E-857F-A889B9D8CF70

P2093

Q34553052-5EE9154F-0F07-4777-9E1F-946C4D3B974E

Q34553052-FC019CD1-E276-47A9-9E2A-FE3696E68370

P2860

Q34553052-032F0F3E-5E7F-4E21-BDD2-4B4EBDB051D1

Q34553052-042D5ABA-262C-44D7-BE7D-43C673BDAEA7

Q34553052-0ADF25DE-FE51-41B6-96C2-2C89FFEF7CB9

Q34553052-0BBA8ED9-498E-4585-BD09-D7DFD76176DC

Q34553052-0C01F2ED-3B8F-41DD-8E58-ACACC2FC8B28

Q34553052-0DC6C819-CEFC-449F-8323-5FFD7D835F08

Q34553052-10827E00-2025-4B8C-B94C-8A9688FDDB31

Q34553052-1329E15B-9D97-4542-A6DB-58F7B807ED75

Q34553052-15AC78CC-3801-4A52-AFF8-FC497B780AE9

Q34553052-162AC227-5E50-42A7-8E8A-5FF1F86E6B48

P2888

Q34553052-263C4D12-111C-47DC-A838-D507465A5A72

P304

Q34553052-5E8FD182-1CD9-40D5-BF56-B56C2A61538D

P31

Q34553052-2d2f1831-0765-44cd-ac34-6eaa15e0c9cc

Q34553052-BD58E4AB-3087-4051-B2A9-83E251828E11

P356

Q34553052-2F6D9F86-ECDD-4B7E-8629-CBCE866092FB

P433

Q34553052-2567E9DE-66D9-4A9F-BEC9-2619807108A1

P478

Q34553052-E313B169-FB2B-4D1F-90D2-E63BB24E9093

P50

Q34553052-81DB2F55-4658-4052-BCA6-51B96421B48F

P577

Q34553052-13C6B871-1033-44A6-9E09-AB4DA800E888

P5875

Q34553052-6091B36D-3E13-4E43-B311-AD589D370200

P6179

Q34553052-6194B61E-9481-464B-9A49-0F5FF4ABCC52

P698

Q34553052-94677265-3FFA-427C-89FE-3491586B58FD

P932

Q34553052-1D7D963B-35C4-4175-9074-59647836FD8C

P356

S11154-008-9104-2

P1433

Reviews in Endocrine and Metabolic Disorders

P1476

Mechanisms of disease: the oxidative stress theory of diabetic neuropathy

@en

P2093

Claudia Figueroa-Romero

http://www.w3.org/2001/XMLSchema#string

Mahdieh Sadidi

http://www.w3.org/2001/XMLSchema#string

P2860

Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation

Biochemistry and molecular cell biology of diabetic complications

Vascular protection: superoxide dismutase isoforms in the vessel wall

The hexosamine signaling pathway: deciphering the "O-GlcNAc code"

Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase

Complex III releases superoxide to both sides of the inner mitochondrial membrane

Transforming growth factor-beta induces cellular injury in experimental diabetic neuropathy

Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice

High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A

P2888

s11154-008-9104-2

P304

301-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11154-008-9104-2

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23176797

http://www.w3.org/2001/XMLSchema#string

P6179

1050676819

http://www.w3.org/2001/XMLSchema#string

P698

18709457

http://www.w3.org/2001/XMLSchema#string

P932

4239697

http://www.w3.org/2001/XMLSchema#string